Abstract:BACKGROUND To investigate the influence of screening history on the diagnosis of cervical intraepithelial neoplasia grade three (CIN III) and cervical cancer in an opportunistic screening program. DESIGN Follow-up study of women with a negative Pap-smear at entry. MATERIALS Records from 41212 women pertaining to cervical specimens in the Pathology Registry of the University Hospital in Tromsø. RESULTS During the 175,673 person-years (pyr) of observation, 396 incident cases (379 of CIN III and 17 of cervical cancer) were identified. The age specific incidence rate was highest among women who were 25 to 29 years old (396 per 100,000 pyr). A Poisson multiple regression model yielded statistically significant positive associations between time since last negative Pap-smear and the incidence of CIN III and cervical cancer. Most CIN III cases were diagnosed subsequently to a CIN I or CIN II diagnosis. Including only women with a CIN III diagnosis directly after a negative Pap-smear in the analyses revealed that women with less than two years (Relative rate (RR)= 1.O; 95% CI 0.7-1.4) and three years (RR=0.8; 95% CI 0.4-1.4) since their last negative Pap-smear were not at an increased risk compared with the women with a negative Pap-smear within the last year. Women with three or more years since their last negative Pap-smear were at an increased risk (RR=1.3; 95% CI 0.6 3.2) for CIN III. No meaningful association between number of negative specimens and the risk of CIN III was revealed. CONCLUSION This study indicates that time since last negative Pap-smear does, while number of such does not, influence the risk of CIN III and cervical cancer in an opportunistic screening.

A Novel CdSe/CdS Quantum Dot-based Competitive Fluoroimmunoassay for the Detection of Clenbuterol Residue in Pig Urine Using Magnetic Core/Shell Fe 3 O 4 /Au Nanoparticles as a Solid Carrier

Ultrasensitive Electrochemical Immunoassay Based on Graphene Oxide-Ag Composites for Rapid Determination of Clenbuterol.

An Automated Immunoassay Based on Magnetic Microspheres for the Determination of Clenbuterol in Food

A fluorometric clenbuterol immunoassay using sulfur and nitrogen doped carbon quantum dots

Flow Injection Chemiluminescence Immunosensor for the Determination of Clenbuterol by Immobilizing Coating-Antigen on Carboxylic Resin Beads

A Novel Immunochromatographic Assay (ica) Based on Surface-Enhanced Raman Scattering for the Sensitive and Quantitative Determination of Clenbuterol

Highly luminescent green-emitting Au nanocluster-based multiplex lateral flow immunoassay for ultrasensitive detection of clenbuterol and ractopamine

Fe3O4@Au@Ag Nanoparticles As Surface-Enhanced Raman Spectroscopy Substrates for Sensitive Detection of Clenbuterol Hydrochloride in Pork with the Use of Aptamer Binding

Multiple signal amplification chemiluminescence immunoassay for chloramphenicol using functionalized SiO 2 nanoparticles as probes and resin beads as carriers.

Ultrasensitive Electrochemiluminescent Brombuterol Immunoassay by Applying a Multiple Signal Amplification Strategy Based on a PAMAM-gold Nanoparticle Conjugate As the Bioprobe and Ag@Au Core Shell Nanoparticles As a Substrate

Construction of Dual Signal Amplification Competitive Immunosensor for Detection of Clenbuterol

Fluorescent sensing platform based on green luminescence carbon dots and AuNPs for clenbuterol detection in pork liver

Colorimetric sensing of clenbuterol using gold nanoparticles in the presence of melamine.

Ultrasensitive Electrochemiluminescent Immunosensor for Detecting Brombuterol Based on Quantum Dots-Graphene@Gold Nanoparticles As Signal Enhancer

CdSe/ZnS quantum dots with multi-shell protection: Synthesis and application in the detection of ractopamine residue in swine urine

Highly Sensitive Electrochemiluminescent Immunosensor Based on Gold Nanoparticles-Functionalized Zinc Oxide Nanorod and Poly(amidoamine)-Graphene for Detecting Brombuterol

A molecularly imprinted electrochemiluminescence nanoprobe based on complexes consisting of CdTe and multiwall carbon nanotube for sensitive determination of clenbuterol

Incidence of cervical intraepithelial neoplasia grade III, and cancer of the cervix uteri following a negative Pap‐smear in an opportunistic screening

Colorimetric method for clenbuterol detection based on the enzyme-like activity of magnetic Fe3O4@mSiO2@MMT-SDS nanoparticles

A label-free aptasensor for rapid detection of clenbuterol based on SYBR GREEN I

Rapid and sensitive detection of β-agonists using a portable fluorescence biosensor based on fluorescent nanosilica and a lateral flow test strip